Desentum's Series A Round

Desentum raised a round of funding on January 24, 2017.

Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergen immunotherapy products that are based on switching the immune system's response to allergens…

Articles about Desentum's Series A Round: